Fluorogenic Platform for Real-Time Imaging of Subcellular Payload Release in Antibody–Drug Conjugates
Antibody-drug conjugates (ADCs) represent promising therapeutic constructs to enhance the selective delivery of drugs to target cells; however, attaining precise control over the timing and location of payload release remains challenging due to the complex intracellular processes that define ADC internalization, trafficking, and linker cleavage. In this study, we present novel real-time fluorogenic probes to monitor both subcellular dynamics of ADC trafficking and payload release. We optimized a tandem molecular design of sequential pH- and enzyme-activatable naphthalimide fluorophores to (1) track their subcellular localization along the endolysosomal pathway and (2) monitor linker cleavage with OFF-to-ON fluorescence switches. Live-cell imaging microscopy revealed that fluorogenic ADCs can traffic to the lysosomes and yet require residence time in these subcellular compartments for efficient linker cleavage. Notably, the compact size of fluorogenic naphthalimides did not impair the recognition of target cell surface reporters or the kinetics of payload release. This modular platform is applicable to many ADCs and holds promise to inform their rational design for optimal release profiles and therapeutic efficacy.
Authors
- Adrian D. Hobson (ORCID: https://orcid.org/0000-0003-3948-0577)
- Fabio De Moliner
- Marc Vendrell (ORCID: https://orcid.org/0000-0002-5392-9740)
- X.Y. Shi (ORCID: https://orcid.org/0009-0004-9829-4250)
- Violeta L. Marin
- Christopher C. Marvin (ORCID: https://orcid.org/0000-0003-4984-8435)
- Rachel Wills (ORCID: https://orcid.org/0000-0002-2111-4248)
- Ferran Nadal‐Bufí (ORCID: https://orcid.org/0000-0002-1156-3410)
- Paulin Salomon (ORCID: https://orcid.org/0000-0001-7941-7770)
- Kaixiong Zhou (ORCID: https://orcid.org/0000-0001-5226-8736)
- Michael J. McPherson (ORCID: https://orcid.org/0000-0002-0719-6427)
- Zhi Wang (ORCID: https://orcid.org/0000-0002-6701-8796)
- Zhou Xu
- Kathy Sarris
- Zhongyuan Wang (ORCID: https://orcid.org/0009-0005-7313-0855)
Institutions
- WuXi AppTec (China) (CN)
- Tianjin Economic-Technological Development Area (CN)
- AbbVie (United States) (US)
- MRC Centre for Regenerative Medicine (GB)
- Centre for Inflammation Research (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1021/jacs.4c16842
- Citations
- 15
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 15.68
Funders
- European Research Council